 "Marksans Pharma gains on acquisition of US-based company")
Marksans Pharma has moved higher by 9% to Rs 63.50 on the BSE after the company announced that it has acquired Time-Cap Laboratories, a US-based company through its subsidiary.
“The company through its wholly-owned subsidiary, Marksans Pharma Inc., acquired 100% of the outstanding shares of Time-Cap Laboratories, Inc., “ Marksans Pharma said in a news release.
Time-Cap has a USFDA approved manufacturing facility in Farmingdale, New York and the company has no debt, it added.
“The company through its wholly-owned subsidiary, Marksans Pharma Inc., acquired 100% of the outstanding shares of Time-Cap Laboratories, Inc., “ Marksans Pharma said in a news release.
Time-Cap has a USFDA approved manufacturing facility in Farmingdale, New York and the company has no debt, it added.
“Time-Cap offers Marksans an ideal platform to expand its operation in the US. This strategic acquisition helps Marksans to expand its manufacturing capabilities along with product portfolio and penetration into the US,” said Mark Saldanha, managing director and CEO of Marksans Pharma.
The stock opened at Rs 58.85 and touched a high of Rs 64.40 on the BSE. The trading volumes on the counter jumped more than two-fold, with a combined 6.03 million shares changing hands till 1033 hours on the BSE and NSE.
The stock opened at Rs 58.85 and touched a high of Rs 64.40 on the BSE. The trading volumes on the counter jumped more than two-fold, with a combined 6.03 million shares changing hands till 1033 hours on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%